Loading
Latest filing published 30 Sept 2024 for Pressure Biosciences INC, €473.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Alexander Lazarev V (senior executive) discloses dealings in Pressure Biosciences Inc to SEC (Form 4). The record holds 10 filings, for trades running from 29 April 2022 to 27 September 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 30 September 2024 came the latest disclosure, a transaction for €473 in Pressure Biosciences Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations